Dr. Law received his Ph.D. from the University of Alberta in Edmonton, Canada in 2005. During his doctoral studies, under the guidance of Dr. Tom C. Hobman, he identified two pathways by which Rubella virus capsid protein regulates virus assembly. He found that both localization of capsid by the E2 signal peptide and capsid phosphorylation were used to spatially and temporally control nucleocapsid formation and subsequent virus assembly. Since joining the Center for the Study of Hepatitis C in February 2005, his research has focused on elucidating the mechanisms by which a host antiviral protein, termed ZAP, blocks Sindbis virus infection. In addition, he is screening for Sindbis genome fragments that have antiviral activities in search for novel antiviral strategies. Dr. Law has been the recipient of a National Science and Engineering Research Council of Canada fellowship.